Effect of oral nutritional supplement on nutritional status in patients of gastrointestical cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0005887

Enrollment

Registered

2021-02-15

Start date

2015-08-04

Completion date

Unknown

Last updated

2021-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : The product containing omega 3 fatty acid and arginine were used as functional ingredients. The 8-week human intervention trial was performed to evaluate the efficacy of developed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Men and women aged = 20 years were eligible if they had a histologically confirmed diagnosis of gastrointestinal cancer.

Exclusion criteria

Exclusion criteria: People with acute disease (pneumonia, sepsis, shock, etc.), infections, severe disease (heart failure, liver failure, kidney failure, hemodialysis, etc.)

Design outcomes

Primary

Measure	Time frame
24hr recall nutritional intake assessment	—

Secondary

Measure	Time frame
Scored Patient-Generated Subjective Global Assessment	—

Countries

Korea, Republic of

Contacts

Public ContactJinmin Kim

Sookmyung Women's Hospital

Outcome results